Clinical data | |
---|---|
Routes of administration | Topical (ointment, eye drops) |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.217.969 |
Chemical and physical data | |
Formula | C25H26F4N2O2 |
Molar mass | 462.489 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Mapracorat (INN, code names BOL-303242-X, ZK-245186[1]) is an anti-inflammatory drug belonging to the experimental class of selective glucocorticoid receptor agonists (SEGRAs). It is in clinical trials for the topical treatment of atopic dermatitis,[2] inflammation following cataract surgery,[3] and allergic conjunctivitis.[4] Preliminary investigation for the treatment of keratoconjunctivitis sicca has been conducted in cellular models.[1]